November 25, 2022

Mirati's (MRTX) Stock Rallies 11% on Buyout Speculations

Mirati Therapeutics MRTX stock was up 11.3% on Wednesday on reports that big cancer drugmakers may offer to buy the company ahead of some upcoming important company milestones.

This post was originally published on this site

Sign Up To Get FREE News, Tips and Offers!